Zacks Investment Research on MSN
Pfizer's Q3 Non-Oncology Performance: Here's What to Expect
Pfizer PFE is due to report third-quarter 2025 results on Nov. 4. All eyes will be on sales of Pfizer’s oncology drugs, which account for more than 25% of the company’s total revenues. Pfizer’s key ...
A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". SHANGHAI, Nov. 28, 2022 /PRNewswire/ -- On November 26, 2022, Shanghai ...
Getting a COVID booster could save your life, even if you’ve had multiple prior infections and vaccinations. A study, ...
CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT-154, a self-amplifying (sa-mRNA) COVID-19 vaccine, compared to Pfizer ...
Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...
Barchart on MSN
Pfizer’s Q3 2025 Earnings: What to Expect
Pfizer is expected to report its third-quarter results next month, and analysts are projecting a double-digit decline in its ...
FILE - The Pfizer logo is displayed at the company's headquarters, Feb. 5, 2021, in New York. Sales of Pfizer’s COVID-19 vaccine and treatment in the second quarter propelled the pharmaceutical giant ...
A wave of social media posts has misleadingly interpreted a recent statement made by the European Commission, framing it as a bombshell admission that COVID-19 vaccines were passed without proper ...
Arcturus Therapeutics ARCT and partner CSL Seqirus, a renowned vaccine company, together reported encouraging results from a 12-month follow-up analysis of a late-stage study evaluating a booster dose ...
Valneva’s plans to establish its COVID-19 vaccine as a booster to Pfizer and BioNTech’s Comirnaty have taken a blow, with a clinical trial of the shot eliciting “only a marginally increased ...
Sales of Pfizer’s COVID-19 vaccine and treatment in the second quarter propelled the pharmaceutical giant to the largest quarterly sales in its history. The coronavirus vaccine Comirnaty brought in $8 ...
FILE - The Pfizer logo is displayed at the company's headquarters, Feb. 5, 2021, in New York. Sales of Pfizer’s COVID-19 vaccine and treatment in the second quarter propelled the pharmaceutical giant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback